LVIVO-TaVec400 product
IIT2025143
Phase 1 mab active
Quick answer
LVIVO-TaVec400 product for Multiple Myeloma (MM) is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Multiple Myeloma (MM)
- Phase
- Phase 1
- Modality
- mab
- Status
- active